Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Facts and controversies in the use of trastuzumab in the adjuvant setting.
Dinh P, de Azambuja E, Cardoso F, Piccart-Gebhart MJ. Dinh P, et al. Nat Clin Pract Oncol. 2008 Nov;5(11):645-54. doi: 10.1038/ncponc1219. Epub 2008 Sep 9. Nat Clin Pract Oncol. 2008. PMID: 18779850 Review.
Adjuvant chemotherapy in 2005: standards and beyond.
Piccart MJ, de Valeriola D, Dal Lago L, de Azambuja E, Demonty G, Lebrun F, Bernard-Marty Ch, Colozza M, Cufer T. Piccart MJ, et al. Breast. 2005 Dec;14(6):439-45. doi: 10.1016/j.breast.2005.08.004. Epub 2005 Sep 26. Breast. 2005. PMID: 16188441 Review.
Gallen consensus panel divided the many available adjuvant chemotherapy (CT) regimens into those with "standard efficacy" (ACx4, CMFx6) and those with "superior efficacy" (FA(E)Cx6, CA(E)Fx6, A(E)-->CMF, TACx6, ACx4--> paclitaxel (P)x4 or docetaxel (D)x …
Gallen consensus panel divided the many available adjuvant chemotherapy (CT) regimens into those with "standard efficacy" (ACx4, CMFx6) and …
Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.
Colozza M, de Azambuja E, Cardoso F, Bernard C, Piccart MJ. Colozza M, et al. Oncologist. 2006 Feb;11(2):111-25. doi: 10.1634/theoncologist.11-2-111. Oncologist. 2006. PMID: 16476832 Review.
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm).
de Castro Junior G, Puglisi F, de Azambuja E, El Saghir NS, Awada A. de Castro Junior G, et al. Crit Rev Oncol Hematol. 2006 Jul;59(1):40-50. doi: 10.1016/j.critrevonc.2006.02.007. Epub 2006 Apr 4. Crit Rev Oncol Hematol. 2006. PMID: 16600618 Review.
Many drugs that target human tumors, like bevacizumab and some VEGF-receptor tyrosine-kinase inhibitors (e.g., BAY 43-9006, SU11248 and PTK787/ZK222584) have been studied in clinical trials, with favorable toxicity reports and encouraging results in advanced colorectal can …
Many drugs that target human tumors, like bevacizumab and some VEGF-receptor tyrosine-kinase inhibitors (e.g., BAY 43-9006, SU11248 a …
The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours.
Mano MS, Rosa DD, De Azambuja E, Ismael GF, Durbecq V. Mano MS, et al. Cancer Treat Rev. 2007 Feb;33(1):64-77. doi: 10.1016/j.ctrv.2006.10.001. Epub 2006 Nov 17. Cancer Treat Rev. 2007. PMID: 17113234 Review.
There is also evidence that these tumours are relatively resistant to anti-oestrogen therapy (tamoxifen) but not to oestrogen deprivation (e.g. with aromatase inhibitors). ...
There is also evidence that these tumours are relatively resistant to anti-oestrogen therapy (tamoxifen) but not to oestrogen deprivation ( …
Achievements in systemic therapies in the pregenomic era in metastatic breast cancer.
Colozza M, de Azambuja E, Personeni N, Lebrun F, Piccart MJ, Cardoso F. Colozza M, et al. Oncologist. 2007 Mar;12(3):253-70. doi: 10.1634/theoncologist.12-3-253. Oncologist. 2007. PMID: 17405890 Review.
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
de Azambuja E, Cardoso F, de Castro G Jr, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M. de Azambuja E, et al. Br J Cancer. 2007 May 21;96(10):1504-13. doi: 10.1038/sj.bjc.6603756. Epub 2007 Apr 24. Br J Cancer. 2007. PMID: 17453008 Free PMC article.
Trastuzumab (herceptin) for early-stage breast cancer.
Ismael G, Rosa DD, de Azambuja E, Braga S, Piccart-Gebhart M. Ismael G, et al. Hematol Oncol Clin North Am. 2007 Apr;21(2):239-56. doi: 10.1016/j.hoc.2007.03.003. Hematol Oncol Clin North Am. 2007. PMID: 17512447 Review.
Molecular targeted therapies in breast cancer: where are we now?
Widakowich C, de Azambuja E, Gil T, Cardoso F, Dinh P, Awada A, Piccart-Gebhart M. Widakowich C, et al. Int J Biochem Cell Biol. 2007;39(7-8):1375-87. doi: 10.1016/j.biocel.2007.04.015. Epub 2007 May 4. Int J Biochem Cell Biol. 2007. PMID: 17543572 Review.
Trastuzumab for early breast cancer: current status and future directions.
Dinh P, de Azambuja E, Piccart-Gebhart MJ. Dinh P, et al. Clin Adv Hematol Oncol. 2007 Sep;5(9):707-17. Clin Adv Hematol Oncol. 2007. PMID: 17982412 Review.
208 results
Jump to page
Feedback